Copyright Reports & Markets. All rights reserved.

Global Anti-Migraine Drugs Sales Market Report 2021

Buy now

1 Anti-Migraine Drugs Market Overview

  • 1.1 Anti-Migraine Drugs Product Scope
  • 1.2 Anti-Migraine Drugs Segment by Type
    • 1.2.1 Global Anti-Migraine Drugs Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Triptans
    • 1.2.3 Ergots
    • 1.2.4 Others
  • 1.3 Anti-Migraine Drugs Segment by Application
    • 1.3.1 Global Anti-Migraine Drugs Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Women
    • 1.3.3 Men
  • 1.4 Anti-Migraine Drugs Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Anti-Migraine Drugs Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Anti-Migraine Drugs Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Anti-Migraine Drugs Price Trends (2016-2027)

2 Anti-Migraine Drugs Estimates and Forecasts by Region

  • 2.1 Global Anti-Migraine Drugs Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Anti-Migraine Drugs Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Anti-Migraine Drugs Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Anti-Migraine Drugs Revenue Market Share by Region (2016-2021)
  • 2.3 Global Anti-Migraine Drugs Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Anti-Migraine Drugs Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Anti-Migraine Drugs Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Anti-Migraine Drugs Estimates and Projections (2016-2027)
    • 2.4.2 Europe Anti-Migraine Drugs Estimates and Projections (2016-2027)
    • 2.4.3 China Anti-Migraine Drugs Estimates and Projections (2016-2027)
    • 2.4.4 Japan Anti-Migraine Drugs Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Anti-Migraine Drugs Estimates and Projections (2016-2027)
    • 2.4.6 India Anti-Migraine Drugs Estimates and Projections (2016-2027)

3 Global Anti-Migraine Drugs Competition Landscape by Players

  • 3.1 Global Top Anti-Migraine Drugs Players by Sales (2016-2021)
  • 3.2 Global Top Anti-Migraine Drugs Players by Revenue (2016-2021)
  • 3.3 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Migraine Drugs as of 2020)
  • 3.4 Global Anti-Migraine Drugs Average Price by Company (2016-2021)
  • 3.5 Manufacturers Anti-Migraine Drugs Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Anti-Migraine Drugs Market Size by Type

  • 4.1 Global Anti-Migraine Drugs Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Anti-Migraine Drugs Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Anti-Migraine Drugs Price by Type (2016-2021)
  • 4.2 Global Anti-Migraine Drugs Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Anti-Migraine Drugs Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Anti-Migraine Drugs Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Anti-Migraine Drugs Price Forecast by Type (2022-2027)

5 Global Anti-Migraine Drugs Market Size by Application

  • 5.1 Global Anti-Migraine Drugs Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Anti-Migraine Drugs Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Anti-Migraine Drugs Price by Application (2016-2021)
  • 5.2 Global Anti-Migraine Drugs Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Anti-Migraine Drugs Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Anti-Migraine Drugs Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Anti-Migraine Drugs Price Forecast by Application (2022-2027)

6 North America Anti-Migraine Drugs Market Facts & Figures

  • 6.1 North America Anti-Migraine Drugs Sales by Company
    • 6.1.1 North America Anti-Migraine Drugs Sales by Company (2016-2021)
    • 6.1.2 North America Anti-Migraine Drugs Revenue by Company (2016-2021)
  • 6.2 North America Anti-Migraine Drugs Sales Breakdown by Type
    • 6.2.1 North America Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
  • 6.3 North America Anti-Migraine Drugs Sales Breakdown by Application
    • 6.3.1 North America Anti-Migraine Drugs Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Anti-Migraine Drugs Sales Breakdown by Application (2022-2027)

7 Europe Anti-Migraine Drugs Market Facts & Figures

  • 7.1 Europe Anti-Migraine Drugs Sales by Company
    • 7.1.1 Europe Anti-Migraine Drugs Sales by Company (2016-2021)
    • 7.1.2 Europe Anti-Migraine Drugs Revenue by Company (2016-2021)
  • 7.2 Europe Anti-Migraine Drugs Sales Breakdown by Type
    • 7.2.1 Europe Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Anti-Migraine Drugs Sales Breakdown by Application
    • 7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Anti-Migraine Drugs Market Facts & Figures

  • 8.1 China Anti-Migraine Drugs Sales by Company
    • 8.1.1 China Anti-Migraine Drugs Sales by Company (2016-2021)
    • 8.1.2 China Anti-Migraine Drugs Revenue by Company (2016-2021)
  • 8.2 China Anti-Migraine Drugs Sales Breakdown by Type
    • 8.2.1 China Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
  • 8.3 China Anti-Migraine Drugs Sales Breakdown by Application
    • 8.3.1 China 157 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 157 Sales Breakdown by Application (2022-2027)

9 Japan Anti-Migraine Drugs Market Facts & Figures

  • 9.1 Japan Anti-Migraine Drugs Sales by Company
    • 9.1.1 Japan Anti-Migraine Drugs Sales by Company (2016-2021)
    • 9.1.2 Japan Anti-Migraine Drugs Revenue by Company (2016-2021)
  • 9.2 Japan Anti-Migraine Drugs Sales Breakdown by Type
    • 9.2.1 Japan Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Anti-Migraine Drugs Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Anti-Migraine Drugs Market Facts & Figures

  • 10.1 Southeast Asia Anti-Migraine Drugs Sales by Company
    • 10.1.1 Southeast Asia Anti-Migraine Drugs Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Anti-Migraine Drugs Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Anti-Migraine Drugs Sales Breakdown by Type
    • 10.2.1 Southeast Asia Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Anti-Migraine Drugs Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Anti-Migraine Drugs Market Facts & Figures

  • 11.1 India Anti-Migraine Drugs Sales by Company
    • 11.1.1 India Anti-Migraine Drugs Sales by Company (2016-2021)
    • 11.1.2 India Anti-Migraine Drugs Revenue by Company (2016-2021)
  • 11.2 India Anti-Migraine Drugs Sales Breakdown by Type
    • 11.2.1 India Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
  • 11.3 India Anti-Migraine Drugs Sales Breakdown by Application
    • 11.3.1 India Anti-Migraine Drugs Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Anti-Migraine Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Anti-Migraine Drugs Business

  • 12.1 Eli Lilly
    • 12.1.1 Eli Lilly Corporation Information
    • 12.1.2 Eli Lilly Business Overview
    • 12.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Eli Lilly Anti-Migraine Drugs Products Offered
    • 12.1.5 Eli Lilly Recent Development
  • 12.2 Abbott
    • 12.2.1 Abbott Corporation Information
    • 12.2.2 Abbott Business Overview
    • 12.2.3 Abbott Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Abbott Anti-Migraine Drugs Products Offered
    • 12.2.5 Abbott Recent Development
  • 12.3 Eisai
    • 12.3.1 Eisai Corporation Information
    • 12.3.2 Eisai Business Overview
    • 12.3.3 Eisai Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Eisai Anti-Migraine Drugs Products Offered
    • 12.3.5 Eisai Recent Development
  • 12.4 Allergan
    • 12.4.1 Allergan Corporation Information
    • 12.4.2 Allergan Business Overview
    • 12.4.3 Allergan Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Allergan Anti-Migraine Drugs Products Offered
    • 12.4.5 Allergan Recent Development
  • 12.5 Endo
    • 12.5.1 Endo Corporation Information
    • 12.5.2 Endo Business Overview
    • 12.5.3 Endo Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Endo Anti-Migraine Drugs Products Offered
    • 12.5.5 Endo Recent Development
  • 12.6 GlaxoSmithKline
    • 12.6.1 GlaxoSmithKline Corporation Information
    • 12.6.2 GlaxoSmithKline Business Overview
    • 12.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 GlaxoSmithKline Anti-Migraine Drugs Products Offered
    • 12.6.5 GlaxoSmithKline Recent Development
  • 12.7 Impax Laboratories
    • 12.7.1 Impax Laboratories Corporation Information
    • 12.7.2 Impax Laboratories Business Overview
    • 12.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Impax Laboratories Anti-Migraine Drugs Products Offered
    • 12.7.5 Impax Laboratories Recent Development
  • 12.8 Pfizer
    • 12.8.1 Pfizer Corporation Information
    • 12.8.2 Pfizer Business Overview
    • 12.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Pfizer Anti-Migraine Drugs Products Offered
    • 12.8.5 Pfizer Recent Development
  • 12.9 AstraZeneca
    • 12.9.1 AstraZeneca Corporation Information
    • 12.9.2 AstraZeneca Business Overview
    • 12.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 AstraZeneca Anti-Migraine Drugs Products Offered
    • 12.9.5 AstraZeneca Recent Development
  • 12.10 Bayer
    • 12.10.1 Bayer Corporation Information
    • 12.10.2 Bayer Business Overview
    • 12.10.3 Bayer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Bayer Anti-Migraine Drugs Products Offered
    • 12.10.5 Bayer Recent Development
  • 12.11 Johnson & Johnson
    • 12.11.1 Johnson & Johnson Corporation Information
    • 12.11.2 Johnson & Johnson Business Overview
    • 12.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Johnson & Johnson Anti-Migraine Drugs Products Offered
    • 12.11.5 Johnson & Johnson Recent Development
  • 12.12 Merck
    • 12.12.1 Merck Corporation Information
    • 12.12.2 Merck Business Overview
    • 12.12.3 Merck Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Merck Anti-Migraine Drugs Products Offered
    • 12.12.5 Merck Recent Development
  • 12.13 Teva
    • 12.13.1 Teva Corporation Information
    • 12.13.2 Teva Business Overview
    • 12.13.3 Teva Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Teva Anti-Migraine Drugs Products Offered
    • 12.13.5 Teva Recent Development
  • 12.14 Amgen
    • 12.14.1 Amgen Corporation Information
    • 12.14.2 Amgen Business Overview
    • 12.14.3 Amgen Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Amgen Anti-Migraine Drugs Products Offered
    • 12.14.5 Amgen Recent Development

13 Anti-Migraine Drugs Manufacturing Cost Analysis

  • 13.1 Anti-Migraine Drugs Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Anti-Migraine Drugs
  • 13.4 Anti-Migraine Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Anti-Migraine Drugs Distributors List
  • 14.3 Anti-Migraine Drugs Customers

15 Market Dynamics

  • 15.1 Anti-Migraine Drugs Market Trends
  • 15.2 Anti-Migraine Drugs Drivers
  • 15.3 Anti-Migraine Drugs Market Challenges
  • 15.4 Anti-Migraine Drugs Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Anti-Migraine Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Triptans
    Ergots
    Others

    Segment by Application
    Women
    Men

    The Anti-Migraine Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-Migraine Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Eli Lilly
    Abbott
    Eisai
    Allergan
    Endo
    GlaxoSmithKline
    Impax Laboratories
    Pfizer
    AstraZeneca
    Bayer
    Johnson & Johnson
    Merck
    Teva
    Amgen

    Buy now